Tencent Music Entertainment Group (TME) News
Market Cap: $12.04B
Avg Volume: 8.21M
Industry: Internet Content & Information
Sector: Communication Services
4 Stocks Raising Dividends by More Than 10%
In a market where income-focused investors seek dividend reliability, four companies, from Wall Street heavyweights to international players, are stepping up with substantial payout hikes. JPMorgan Chase, Williams-Sonoma, Tencent Music Entertainment, and CareTrust REIT have each announced dividend increases of 10% or more, signaling financial strength and a strong commitment to shareholder returns.
marketbeat.com
Read More
Tencent Music: Seizing Opportunities In Music Business Amid Hurdles
Tencent Music's 4Q24 shows strong growth in online music services but continued weakness in social entertainment, leading to a cautious stock outlook. Music subscription revenue grew 18% y/y, driven by increased paying users and ARPU, while social entertainment revenue declined 13% y/y. TME's valuation should focus on the music subscription segment, implying a 10% downside to $13/share, given the limited value of social entertainment.
seekingalpha.com
Read More
Why Tencent Music Entertainment Group Was Music to Investor Ears This Week
The market very much liked what it heard coming from China's Tencent Music Entertainment Group (TME -1.96%) this week. A better-than-expected earnings report the company published on Tuesday was enough of a hit to rise the stock nearly 12% higher in price over the period, according to data compiled by S&P Global Market Intelligence.
fool.com
Read More
Tencent Music beats estimates as AI enhances user experience
Tencent Music Entertainment Group shares surged following fourth-quarter earnings that exceeded expectations that reinforced its strategic focus on high-quality growth and artificial intelligence (AI) to enhance user engagement. Tencent Music's total revenue rose 8.2% year-over-year to RMB7.46 billion, exceeding consensus estimates by 2.2%.
proactiveinvestors.com
Read More
Tencent Music Entertainment Group (TME) Q4 2024 Earnings Call Transcript
Tencent Music Entertainment Group (NYSE:TME ) Q4 2024 Earnings Conference Call March 18, 2025 7:00 AM ET Company Participants Millicent Tu - Head of Investor Relations Cussion Pang - Executive Chairman Ross Liang - Chief Executive Officer Shirley Hu - Chief Financial Officer Conference Call Participants Alicia Yap - Citi Lincoln Kong - Goldman Sachs Group, Inc. Fang Wei - Mizuho Securities Wei Xiong - UBS Alex Yao - JP Morgan Millicent Tu Good evening and good morning, and welcome to Tencent Music Entertainment Group's Fourth Quarter and Full Year 2024 Earnings Conference Call. I'm Millicent Tu.
seekingalpha.com
Read More
Tencent Music Entertainment beats quarterly revenue estimates
Tencent Music Entertainment beat analysts' expectations for fourth-quarter revenue on Tuesday, backed by the strong growth of streaming services.
reuters.com
Read More
Cancer Grand Challenges Announces Seven New Challenges Representing Some of the Toughest Questions Facing Cancer Research Today
BOSTON--(BUSINESS WIRE)--Cancer Grand Challenges announces seven new challenges representing some of the toughest questions facing cancer research today.
businesswire.com
Read More
TME vs. RELX: Which Stock Is the Better Value Option?
Investors interested in stocks from the Internet - Content sector have probably already heard of Tencent Music Entertainment Group Sponsored ADR (TME) and RELX PLC (RELX). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.com
Read More
TME or TTGT: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Internet - Content sector have probably already heard of Tencent Music Entertainment Group Sponsored ADR (TME) and TechTarget (TTGT). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.com
Read More
Here's Why Tencent Music Entertainment Group (TME) is Poised for a Turnaround After Losing -12.04% in 4 Weeks
The heavy selling pressure might have exhausted for Tencent Music Entertainment Group (TME) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
zacks.com
Read More
Tencent Music Entertainment Group (TME) Q3 2024 Earnings Call Transcript
Tencent Music Entertainment Group (NYSE:TME ) Q3 2024 Earnings Conference Call November 12, 2024 6:00 AM ET Company Participants Millicent Tu - Head of Investor Relations Cussion Pang - Executive Chairman Ross Liang - Chief Executive Officer Shirley Hu - Chief Financial Officer Conference Call Participants Yang Liu - Morgan Stanley Lincoln Kong - Goldman Sachs Group, Inc. Alicia Yap - Citigroup Inc. Lei Zhang - Bank of America Merrill Lynch Fang Wei - Mizuho Securities USA Wei Xiong - UBS Maggie Ye - CLSA Thomas Chong - Jefferies Millicent Tu Good evening, good morning, and welcome to Tencent Music Entertainment Group's Third Quarter 2024 Earnings Conference Call. I'm Millicent Tu, Head of IR.
seekingalpha.com
Read More
Tencent Music users tune out of karaoke, live streaming services
China's Spotify analogue Tencent Music Entertainment Group posted 6.8% increase in total revenues for the third quarter of 2024, hitting 7.02 billion Chinese yuan (around US$1 billion). TME attributed the increase to higher music subscriptions, although this was partially offset by lower revenues from “social entertainment services and others”.
proactiveinvestors.com
Read More
Tencent Music Entertainment misses quarterly revenue estimates
Tencent Music Entertainment missed quarterly revenue estimates on Tuesday, as Beijing's crackdown on online gambling continues to impact its social entertainment segment.
reuters.com
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Tencent Music Entertainment Group (TME)
Tencent Music Entertainment Group (TME) possesses solid growth attributes, which could help it handily outperform the market.
zacks.com
Read More
TME vs. TTGT: Which Stock Is the Better Value Option?
Investors looking for stocks in the Internet - Content sector might want to consider either Tencent Music Entertainment Group Sponsored ADR (TME) or TechTarget (TTGT). But which of these two stocks presents investors with the better value opportunity right now?
zacks.com
Read More
Wall Street Analysts Believe Tencent Music Entertainment Group (TME) Could Rally 26.83%: Here's is How to Trade
The consensus price target hints at a 26.8% upside potential for Tencent Music Entertainment Group (TME). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
zacks.com
Read More
Tencent Music Entertainment Group Inks Strategic Partnership with Galaxy Corporation
Expanding TME's Global Footprint to Elevate International Music Experiences SHENZHEN, China , Oct. 17, 2024 /PRNewswire/ -- Tencent Music Entertainment Group (TME) today announced a strategic partnership with Galaxy Corporation, the agency representing the influential global musician G-Dragon, for his upcoming regional tour. The collaboration marks a significant step forward in TME's ambitions to expand its global presence and further solidify its position in the international music scene.
prnewswire.com
Read More
Many Things To Like About Tencent Music Entertainment
I maintain a Buy rating for Tencent Music Entertainment, taking into consideration the multiple positives for the stock. TME's online music services revenue is resilient despite China's economic slowdown. The introduction of the new higher-priced Super VIP plan is expected to enhance ARPPU and drive future revenue growth for TME.
seekingalpha.com
Read More
3 Key Stocks to Ride China's Stimulus-Driven Growth
China's economy has struggled in recent months amid a depressed level of consumer confidence and a devastating housing bust coupled with weak credit demand. Late in September—just after the U.S. Federal Reserve announced its first federal funds rate cut in several years—the People's Bank of China unveiled a three-part monetary stimulus program to reduce reserve requirement ratios (the amount of cash banks are required to keep on hand), mortgage rates and down payment requirements, and more.
benzinga.com
Read More
Why Chinese Stocks Were Slipping Late This Week After Monster Price Rises
No rally, not even one pushed hard by the Chinese government, can last forever.
fool.com
Read More
Why Chinese Stocks Continued to Zoom Higher on Wednesday
Lingering optimism about the future of the country's enterprises continued to drive demand for them higher; rising tensions elsewhere in the world also played a role.
fool.com
Read More
Tencent Music Entertainment Group (TME) Shares Up 6% on Oct 2
Shares of Tencent Music Entertainment Group (TME, Financial) surged 6.00% in mid-day trading on Oct 2. The stock reached an intraday high of $14.05, before settling at $13.52, up from its previous close of $12.75.
gurufocus.com
Read More
Is Tencent Music Entertainment Group (TME) a Solid Growth Stock? 3 Reasons to Think "Yes"
Tencent Music Entertainment Group (TME) possesses solid growth attributes, which could help it handily outperform the market.
zacks.com
Read More
TME vs. ABNB: Which Stock Is the Better Value Option?
Investors interested in Internet - Content stocks are likely familiar with Tencent Music Entertainment Group Sponsored ADR (TME) and Airbnb, Inc. (ABNB). But which of these two stocks is more attractive to value investors?
zacks.com
Read More
Why Tencent, Tencent Music Entertainment, and iQiyi All Soared Today
On Tuesday, the Chinese government cut interest rates, lowered bank reserve requirements, and lowered down payments on homes. Shares of consumer-focused companies in China rallied on news of the stimulus measures.
fool.com
Read More
Top 3 Tech And Telecom Stocks That May Rocket Higher This Quarter
The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.
benzinga.com
Read More
Tencent Music Entertainment Group Launches Global Music Outreach Initiative
Singapore Kicks Off the First Stop of TME's Music Journey to the World SHENZHEN, China , Sept. 12, 2024 /PRNewswire/ -- On September 11, 2024 , Tencent Music Entertainment Group (TME) announced the launch of its Global Music Outreach Initiative, which will bring together talented Chinese music artists and their works to be showcased on prominent stages worldwide.
prnewswire.com
Read More
Top 3 Tech And Telecom Stocks You'll Regret Missing This Quarter
The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.
benzinga.com
Read More
Tencent Music Entertainment Group (TME) Q2 2024 Earnings Call Transcript
Tencent Music Entertainment Group (NYSE:TME ) Q2 2024 Results Conference Call August 13, 2024 7:00 AM ET Company Participants Millicent Tu - Head of IR Cussion Pang - Executive Chairman Ross Liang - CEO Shirley Hu - CFO Conference Call Participants Alicia Yap - Citigroup Lincoln Kong - Goldman Sachs Alex Poon - Morgan Stanley Lei Zhang - Bank of America Merrill Lynch Wei Xiong - UBS Thomas Chong - Jefferies Millicent Tu Good evening, and good morning, and welcome to Tencent Music Entertainment Second Quarter 2024 Earnings Conference Call. I'm Millicent Tu, Head of IR.
seekingalpha.com
Read More
Why You Shouldn't Count Out Tencent Music Stock After Earnings
Tencent Music Entertainment Group NYSE: TME is the largest music streaming company in China. The company's shares have been a bright spot for investors in the country over the past 52 weeks, providing a total return of 84%.
marketbeat.com
Read More
Tencent Music's Average Revenue Per User Focus Signals Potential Profit Growth, Says Analyst
BofA Securities analyst Lei Zhang reiterated a Buy rating on Tencent Music Entertainment Group – ADR TME with a price target of $15, down from $18.
benzinga.com
Read More
Tencent News: Why Is TME Stock Plunging 15% Today?
Tencent Music Entertainment (NYSE: TME ) stock is falling on Tuesday after the online music entertainment platform company reported earnings for the second quarter of 2024. The bad news for investors in TME stock starts with its adjusted earnings per share of 65 cents.
investorplace.com
Read More
Tencent US-Listed Stock Dives as Karaoke Unit Revenue Plummets
American depositary receipts (ADRs) of Tencent Music Entertainment Group (TME) sank Tuesday after the Chinese music streaming service posted worse-than-expected social entertainment services revenue as it dealt with government restrictions on the industry.
investopedia.com
Read More
On Holding Reports Mixed Q2 Results, Joins Tencent Music Entertainment And Other Big Stocks Moving Lower In Tuesday Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Tuesday.
benzinga.com
Read More
Tencent Music Entertainment shares slump on drop in karaoke platform users
Tencent Music Entertainment Group's New York listed shares slumped in Tuesday's pre-market session as the Chinese streaming giant said a sharp drop in the number of people using its karaoke platforms had driven a slump in its second quarter revenue.
marketwatch.com
Read More
Surging Earnings Estimates Signal Upside for Tencent Music Entertainment Group (TME) Stock
Tencent Music Entertainment Group (TME) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zacks.com
Read More
Tencent Music Entertainment Group Sponsored ADR (TME) is a Great Momentum Stock: Should You Buy?
Does Tencent Music Entertainment Group Sponsored ADR (TME) have what it takes to be a top stock pick for momentum investors? Let's find out.
zacks.com
Read More
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target
The SON-1010 studies have together enrolled 61 subjects, to date, as dose escalation continues in SB101 and SB221 at higher levelsPatients have received up to 25 cycles of SON-1010 as monotherapy and 10 cycles of SON-1010 with atezolizumab (Tecentriq®) without dose-limiting toxicity at any dose levelCytokine data reveals about 10-fold extended half-life for SON-1010 compared with rhIL-12 that induces prolonged and controlled IFNγ responses, with no evidence of cytokine release syndrome at any doseClinical benefit was seen at four months post-initiation of dosing in 35% of evaluable patients (8/23) with advanced solid tumors PRINCETON, NJ / ACCESSWIRE / May 20, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that the safety of SON-1010 dosing has been formally reviewed in both of the current Phase 1 clinical trials and the Company is now increasing the target dose of SON-1010 during dose escalation. SON-1010 is a proprietary version of recombinant human interleukin-12 (rhIL-12), configured using Sonnet's Fully Human Albumin Binding (FHAB®) platform, which extends the half-life and activity of the IL-12 component due to binding native albumin in the serum and targets the tumor microenvironment (TME) by strongly binding gp60 and Secreted Protein Acidic and Rich in Cysteine (SPARC). SB101 is a Phase 1 multiple-ascending dose (MAD) trial in adult patients with advanced solid tumors (NCT05352750) that commenced in Q2 2022 and is currently enrolling the sixth dose cohort. SB221 is a Phase 1b/2a dose-escalation and proof-of-concept study of the combination of SON-1010 with atezolizumab (in collaboration with Genentech, a member of the Roche Group), in a study focused on platinum-resistant ovarian cancer (PROC) (NCT05756907) that started in Q4 2023, now enrolling the fourth dose cohort. In addition, SON-1010 was studied in SB102, which was a Phase 1 single-ascending dose (SAD) trial in healthy volunteers (NCT05408572) that started in Q3 2022; the results were recently published (Kenney, et al, Frontiers in Immunology, 2024).Safety in both of the active cancer trials has been reviewed by their respective Safety Review Committees at each step during dose escalation. Both trials use a ‘desensitizing' first dose to take advantage of the known tachyphylaxis with rhIL-12, which minimizes toxicity and allows higher maintenance doses. No dose-limiting toxicities or related serious adverse events have occurred to date. The safety and toxicity profile that has developed is typical for a Phase 1 oncology trial, with the majority of adverse events (AEs) being reported as mild. All have been transient, with no evidence of cytokine release syndrome. Of the 25 cancer patients dosed to date and evaluable for follow-up at this latest cutoff, 15 (60%) had stable disease at their first follow-up scan, 8 of whom were progressing at study entry. At four months follow-up, 8 of 23 evaluable patients remained stable at the second CT scan, suggesting clinical benefit of SON-1010 in 35% of the patients."We have now dosed 18 cancer patients at increasing SON-1010 drug levels in the SB101 study, completed dosing in 31 healthy volunteers in SB102, and are rapidly filling the dose-escalation cohorts with 12 subjects enrolled in the first four cohorts of the SB221 combination study," said Richard Kenney, M.D., Sonnet's Chief Medical Officer. "The overall safety and toxicity profile for SON-1010, primarily including local reactions, headache, myalgia, and fatigue, mimics the published experience with rhIL-12, which prompted us to raise the target dose to enhance potential efficacy. The SB102 study allowed us to generate clean data for the pharmacokinetic (PK) and pharmacodynamic (PD) analyses, enabling simulation of the effect of multiple doses with the help of a continual reassessment model of PK and PD. This modeling suggests target-mediated drug disposition (TMDD), which supports the mechanism of the FHAB being directed to tumor tissue. The combination of SON-1010 with atezolizumab may benefit from the ability of IL-12 to turn ‘cold' tumors ‘hot', which upregulates the amount of PD-L1 in the TME."One patient with progressive endometrial sarcoma receiving SON-1010 monotherapy in SB101 had stable disease (SD) for almost 2 years before progressing - her ascites had resolved and tumors had shrunk at one point but she never reached a partial response (PR) by Response Evaluation Criteria in Solid Tumors (RECIST) rules. Cytokine analysis following each dose in that study revealed controlled and prolonged induction of interferon gamma (IFNγ) that peaked at 24 to 48 hours and returned to baseline within 2 to 4 weeks. A small increase in IL-10 was observed with each dose as expected in response to IFNγ. There was either a minimal or no signal for IL-1β, IL-6, IL-8, and TNFα, and there was no indication of any potential for cytokine release syndrome (CRS) at these doses. One patient in Part 1 of SB221 with uterine sarcomas received 8 cycles of the SON-1010/atezolizumab combination therapy every 3 weeks before progressing; another two have received 8 and 10 cycles, respectively, and are continuing on the study. The stable AE profiles despite dose escalation led us to reevaluate the target dose, so the Company has added groups in both studies to evaluate 1200 ng/kg SON-1010 as a maintenance dose (the molar equivalent of 800 ng/kg rhIL-12). Finally, Part 2 of the SB221 combination study has been trimmed to remove the monotherapy arm."The findings to date in these two trials represent significant progress for the SON-1010 molecule", said Robert Wenham, M.D., Chair, Department of GYN Oncology at Moffitt Cancer Center and the Lead Principal Investigator for SB221. "Multiple strategies to present IL-12 safely have been tried over the past two decades with little evidence of improved tolerability in humans, yet the preclinical models continue to suggest that induction of IFNγ in the TME can activate an effective anti-tumor response. This also results in the local induction of PD-L1. Adding a cohort to increase the target MTD of SON-1010, an extended PK molecule that is concentrated in the TME, is the right approach at this stage. This will provide a chance to study the safety of SON-1010 monotherapy in SB101, and then in combination with atezolizumab in SB221, along with the clinical effect of the combination on PROC in a limited set of subjects in the expansion cohort later this year. Defining the best dose for SON-1010 is required to allow a direct randomized comparison of the strategy with the standard of care therapy in Part 2.""We are very pleased with the data we are seeing at these higher dose levels of SON-1010, with safety and tolerability being well within expected levels, as well as displaying SON-1010 extended PK/PD, tumor targeting, and clinical activity during treatment," said Pankaj Mohan, Ph.D., Sonnet Founder and Chief Executive Officer. "Research on rhIL-12 in humans has been hindered by toxicity for decades. We believe that the IL-12 component in SON-1010 is presented in a way that is safer, due to the longer half-life, and it is concentrated in the tumor, due to the recurrent binding of the FHAB-associated albumin to SPARC in the TME. It is important to note that many of these patients have been fighting their cancers for a very long time and have exhausted all approved treatment regimens available to them, so seeing tumor shrinkage at any dose is both difficult to achieve and encouraging for future results. We are excited to continue testing the impact of SON-1010 in combination with atezolizumab at these higher dose levels in patients with PROC, who represent a significant unmet medical need, and we expect to have a further update early next year."About SON-1010SON-1010 is a candidate immunotherapeutic recombinant drug that links unmodified single-chain human IL-12 with the albumin-binding domain of the single-chain antibody fragment A10m3. This was selected to bind both at normal pH, as well as at the acidic pH typically found in the TME. The FHAB technology targets tumor and lymphatic tissue, providing a mechanism for dose sparing and an opportunity to improve the safety and efficacy profile of not only IL-12, but a variety of potent immunomodulators that can be added using the platform. Interleukin-12 can orchestrate a robust immune response to many cancers and pathogens. Given the types of proteins induced in the TME, such as the Secreted Protein and Rich in Cysteine (SPARC) and glycoprotein 60 (GP60), several types of cancer such as non-small cell lung cancer, melanoma, head and neck cancer, sarcoma, and some gynecological cancers are particularly relevant for this approach. SON-1010 is designed to deliver IL-12 to local tumor tissue, turning ‘cold' tumors ‘hot' by stimulating IFNγ, which activates innate and adaptive immune cell responses and increases the production of Programed Death Ligand 1 (PD-L1) on tumor cells.About the SB101 Phase 1 TrialThis first-in-human study is primarily designed to evaluate the safety of multiple ascending doses of SON-1010 in cancer patients and will be conducted at several sites across the United States. While the optimal dose is unknown at this stage, the potential to target tumors, the extended PK mechanism and our preclinical data suggest the therapeutic dose may be lower compared to native human IL-12. The study, utilizing a standard 3+3 oncology design in at least five cohorts, should establish the MTD and the recommended Phase 2 dose (RP2D) using monthly subcutaneous injections of SON-1010. The primary endpoint explores the safety and tolerability of SON-1010, with key secondary endpoints intended to measure pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and anti-tumor activity. This study will form the basis for potential combinations with other types of immunotherapies and the future development of bispecific candidates using the FHAB platform.About the SB221 Phase 1b/2a TrialSB221 is a global Phase 1b/2a multicenter, dose-escalation and randomized proof-of-concept study to assess the safety, tolerability, PK, PD, and efficacy of SON-1010 administered subcutaneously (SC), either alone or in combination with atezolizumab given intravenously (IV). The study is designed in Part 1 to rapidly establish the maximum tolerated dose (MTD) of the combination in patients with advanced solid tumors at the lower dose levels. The focus shifts to PROC at higher dose levels using small dose-escalation groups with expansion of the dataset at the recommended Phase 2 dose (RP2D). This would be followed in Part 2 by an assessment in patients with PROC of the potential for improved efficacy of the combination versus the standard of care. Both companies look forward to this collaboration as an opportunity to improve outcomes for patients with ovarian cancer.About Sonnet BioTherapeutics Holdings, Inc.Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action. Known as FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and "hitch-hikes" on human serum albumin (HSA) for transport to target tissues. Sonnet's FHAB was designed to specifically target tumor and lymphatic tissue, with an improved therapeutic window for optimizing the safety and efficacy of immune modulating biologic drugs. FHAB is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies, and vaccines.Tecentriq® (atezolizumab) is a registered trademark of Genentech, a member of the Roche Group.Forward-Looking StatementsThis press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the outcome of the Company's clinical trials, the Company's cash runway, the Company's product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions.These statements may be identified by the use of forward-looking expressions, including, but not limited to, "expect," "anticipate," "intend," "plan," "believe," "estimate," "potential," "predict," "project," "should," "would" and similar expressions and the negatives of those terms. These statements relate to future events or the Company's financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company's filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.Sonnet BioTherapeutics Investor ContactJack YauchSolebury Strategic Communications862-754-1024jyauch@soleburystrat.comSOURCE: Sonnet BioTherapeutics Holdings, Inc.
https://www.accesswire.com
Read More
Wall Street Awaits Economic Data
We have an important week for the markets on tap. Wednesday brings us Consumer Price Index (CPI) numbers for April, which will be preceded by the Producer Price Index (PPI) wholesale report on Tuesday.
zacks.com
Read More
Big Inflation Prints on Deck This Week
Consumer Price Index (CPI) numbers for April will be preceded by the Producer Price Index (PPI) wholesale report on Tuesday.
zacks.com
Read More
Tencent Music Entertainment (TME) Q1 2024 Earnings Call Transcript
Tencent Music Entertainment (NYSE:TME ) Q1 2024 Earnings Conference Call May 13, 2024 7:00 AM ET Company Participants Millicent Tu - Head of Investor Relations Cussion Kar Shun Pang - Executive Chairman Zhu Liang - Chief Executive Officer Min Hu - Chief Financial Officer Conference Call Participants Alicia Yap - Citigroup Alex Poon - Morgan Stanley Lincoln Kong - Goldman Sachs Zhang Lei - Bank of America Merrill Lynch Ellie Jiang - Macquarie Wei Fang - Mizuho Securities Thomas Chong - Jefferies Millicent Tu Good evening, good morning, and welcome to Tencent Music Entertainment Group's First Quarter 2024 Earnings Conference Call. I'm Millicent Tu, Head of IR.
seekingalpha.com
Read More
Tencent Music sees 27.5% jump in net profits despite revenue dip to $937 M in Q1
China's Tencent Music Entertainment Group (TME) faced a mixed financial landscape in the first quarter of fiscal year 2024, as announced on Monday. Tencent Music revenue dips, but profits grow While the company saw a slight revenue decrease of 3.4%, falling to $937 million, it successfully boosted its net profit by 27.
invezz.com
Read More
Tencent Music beats quarterly revenue estimates
China's Tencent Music Entertainment Group , beat first-quarter revenue estimates on Monday, thanks to steady growth in paid subscriptions and advertising services on its Spotify-like music streaming platform.
reuters.com
Read More
4 Top Breakout Stocks to Buy Now for Superb Returns
Rush Street Interactive (RSI), American Public Education (APEI), Tencent Music Entertainment (TME) and Galiano Gold (GAU) have been selected as the breakout stocks for today.
zacks.com
Read More
Tencent Music Entertainment Group Filed 2023 Annual Report on Form 20-F
SHENZHEN, China , April 18, 2024 /PRNewswire/ -- Tencent Music Entertainment Group ("TME", or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, today announced that it has filed its annual report on Form 20-F that includes its audited financial statements for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission (the "SEC") on April 18, 2024, U. S. Eastern Time.
prnewswire.com
Read More
Options Traders Target Tencent Music Entertainment Stock
Options traders are targeting Tencent Music Entertainment Group (NYSE:TME) today, as the stock jumps to its highest level since July 2021.
schaeffersresearch.com
Read More
TME or RELX: Which Is the Better Value Stock Right Now?
Investors interested in Internet - Content stocks are likely familiar with Tencent Music Entertainment Group Sponsored ADR (TME) and RELX PLC (RELX). But which of these two stocks presents investors with the better value opportunity right now?
zacks.com
Read More
5 Profitable PEG-Based GARP Stocks for Investors
Here are five stocks, AEO, JD, PDD, AL and TME, which fit our screening criteria.
zacks.com
Read More
Tencent Music Entertainment (TME) Q4 2023 Earnings Call Transcript
Tencent Music Entertainment (TME) Q4 2023 Earnings Call Transcript
seekingalpha.com
Read More
The Top 7 Under-$10 Stocks to Buy in March 2024
There are some ripe bargains in the stock market this month, which has led to this list of under-$10 stocks to buy. It's fair to say these companies trade at attractive valuations, and many have low market caps too, increasing their attractiveness.
investorplace.com
Read More
Tencent Music Entertainment Group to Report Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024
SHENZHEN, China , Feb. 20, 2024 /PRNewswire/ -- Tencent Music Entertainment Group ("TME", or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, today announced that it will report its unaudited financial results for the fourth quarter and full year of 2023 before the U.S. market opens on Tuesday, March 19, 2024. TME's management will host a Tencent Meeting Webinar on Tuesday, March 19, 2024, at 7:00 A.M.
prnewswire.com
Read More
PERI vs. TME: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Internet - Content sector have probably already heard of Perion Network (PERI) and Tencent Music Entertainment Group Sponsored ADR (TME). But which of these two stocks presents investors with the better value opportunity right now?
zacks.com
Read More
3 Stocks to Bet on for the Future of Streaming
2023 was, in many ways, a challenging year for the media industry. With the decline of traditional distribution channels such as physical media, movie theaters, and cable TV, content producers must shift their business models dramatically to adapt to the changing times.
investorplace.com
Read More
2024 could turn into a ‘trader's market.' Here's how this strategist says you can make the most of that.
The S&P 500 index SPX has three days left this year to try for a fresh record high, which in theory, shouldn't be so hard with a Santa Rally all but teed up.
marketwatch.com
Read More
Tencent Music Entertainment Group Sponsored ADR (TME) Just Overtook the 20-Day Moving Average
Tencent Music Entertainment Group Sponsored ADR (TME) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, TME broke through the 20-day moving average, which suggests a short-term bullish trend.
zacks.com
Read More
Tencent Music Entertainment Group Sponsored ADR (TME) Just Flashed Golden Cross Signal: Do You Buy?
Tencent Music Entertainment Group Sponsored ADR (TME) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, TME's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
zacks.com
Read More
Tencent Music Entertainment Group Announces Management Change
SHENZHEN, China , Nov. 30, 2023 /PRNewswire/ -- Tencent Music Entertainment Group ("TME," or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, today announced that Mr. Lixue Shi has tendered his resignation as the Company's Group Vice President and in his other relevant roles for personal reasons, effective December 31, 2023.
prnewswire.com
Read More
3 Music Streaming Stocks Set to Hit the Right Notes in 2024
These music streaming stocks should be on your watchlist. What I like about these companies is that their valuations are fair, and many of them have great future prospects.
investorplace.com
Read More
Tencent Music 3Q revenue tops estimates as paid subscriptions surge
Tencent Music Entertainment Group on Tuesday announced a 10.8% year-over-year decline in its third quarter 2023 revenue to 6.57 billion yuan (US$900.94 million), due mainly to falling revenue from social entertainment services and other sources. Its top-line results, however, surpassed the analyst consensus forecast of 6.31 billion yuan, according to LSEG data.
proactiveinvestors.com
Read More
Tencent Music Entertainment Group (TME) Q3 2023 Earnings Call Transcript
Tencent Music Entertainment Group (NYSE:TME ) Q3 2023 Earnings Conference Call November 14, 2023 6:00 AM ET Company Participants Millicent Tu - Investor Relations Kar Shun Pang - Executive Chairman Ross Liang - Chief Executive Officer Shirley Hu - Chief Financial Officer Conference Call Participants Alicia Yap - Citigroup Alex Poon - Morgan Stanley Zhang Lei - Bank of America Merrill Lynch Lincoln Kong - Goldman Sachs Thomas Chong - Jefferies Alex Yao - JPMorgan Xueqing Zhang - CICC Wei Xiong - UBS Millicent Tu Good evening, good morning. Welcome to Tencent Music Entertainment Group's Third Quarter 2023 Earnings Webinar.
seekingalpha.com
Read More
China's Tencent Music beats revenue estimates on paid subscriber growth
China's Tencent Music Entertainment beat estimates for third-quarter revenue on Tuesday, helped by steady growth in paid subscriptions on its music streaming platform.
reuters.com
Read More
Tencent Music: Turnaround, Interrupted
Tencent Music's live streaming business is under the regulatory spotlight this year. While online music subscriptions are outperforming, regulatory headwinds threaten to derail hopes of a turnaround. There's still earnings growth potential here, but at current levels, the risk/reward isn't great.
seekingalpha.com
Read More
Alibaba and other Chinese shares bounce back as China reportedly looks to re-energize its stock market
U.S.-listed shares of Chinese internet stocks were rising Friday, snapping back after two sessions of pressure.
marketwatch.com
Read More
Grab These 7 Winning Tech Stocks on Sale Now
While many investors are clamoring for the most popular tech stocks to buy, it's vital to recognize that many of these equities have already posted staggering gains. With the economic landscape currently dotted with concerns — from persistent inflation to alarming job cuts — it might be wise to turn our attention towards more inconspicuous opportunities.
investorplace.com
Read More
5 Well-Known ‘Strong Buy' Stocks Under $10 Could Soar This Fall
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
24/7 Wall Street
Read More
The 3 Most Undervalued Chinese Stocks to Buy in September 2023
In 2023, Chinese stocks have massively underperformed in developed markets contrary to expectations. Investors anticipated a lift from economic growth after the end of the COVID-19 lockdown measures, but this has yet to materialize.
investorplace.com
Read More
2 Stocks to Buy Before They Take Off
Roblox has a popular gaming platform that big brands want exposure to. Tencent Music is seeing more users in China willing to pay up for memberships.
fool.com
Read More
Why Tencent Music Entertainment Stock Was Up This Week
Tencent Music reported better-than-expected earnings results this week. China's leading music service provider is benefiting from broad demand for music streaming.
fool.com
Read More
Tencent Music Entertainment Group (TME) Q2 2023 Earnings Call Transcript
Tencent Music Entertainment Group (NYSE:TME ) Q2 2023 Results Conference Call August 15, 2023 8:00 AM ET Company Participants Tony Yip - Chief Strategy Officer Kar Shun Pang - Executive Chairman Ross Liang - Chief Executive Officer Shirley Hu - Chief Financial Officer Conference Call Participants Alex Yao - JPMorgan Lei Zhang - Bank of America Merrill Lynch Alex Poon - Morgan Stanley Lincoln Kong - Goldman Sachs Alicia Yap - Citicorp Thomas Chong - Jefferies Xueqing Zhang - CICC Tony Yip Good evening and good morning. Welcome to Tencent Music Entertainment Group's Second Quarter 2023 Earnings Webinar.
seekingalpha.com
Read More
Tencent Music sees its subscriber base jump 20% to almost 100m
Tencent Music Entertainment (TME), China's Spotify, has announced a significant surge in both subscribers and revenue. The Shenzhen-based firm, which owns platforms such as QQ Music, Kugo, and Kuwou, said its paying user base hit 99.4 million for the three months ended June 30, up 20% on the same period last year.
proactiveinvestors.com
Read More
China's Tencent Music quarterly revenue rises 5.5%
China's Tencent Music Entertainment Group , said on Tuesday second-quarter revenue rose 5.5% from a year ago, driven by growth in paying users on its Spotify-like music streaming platform and a recovery in the advertising market.
reuters.com
Read More
Tencent Music hopes to flex further subscriber growth with 2Q results Tuesday
Tencent Music Entertainment Group Inc is scheduled to report earnings Tuesday before the bell. The biggest online music platform in China is expected to post second-quarter revenue of $1.01 billion and earnings of $0.14 per share.
proactiveinvestors.com
Read More
Earnings Previews: Canoo, Home Depot, Sea Limited, Tencent Music
After U.S. markets closed on Thursday, IonQ reported a wider-than-expected loss per share while posting revenue of $5.52 million, nearly 27% higher than the consensus estimate and more than double the reported revenue in the year-ago quarter.
247wallst.com
Read More
Tencent Music: It's Time To Tune In
The past 2 years have shown a strong link between Tencent Music's valuation and consensus EPS revisions. I think this has driven recent underperformance. But a reversal might be on the horizon. Based on my research, I anticipate a favorable swing in the next 2-3 years, facilitated by TME's robust online music segment and comprehensive portfolio. Despite my optimistic outlook for EPS revisions, my DCF analysis suggests that TME is trading at over a 60% discount to its intrinsic value of $11.5 a share.
seekingalpha.com
Read More
Best Value Stocks to Buy for July 12th
SOHO, GFF and TME made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 12, 2023.
zacks.com
Read More
5 Top-Ranked Tech Stocks Under $20 That Promise Gains in 2H23
Here we discuss five top-ranked tech stocks, EGAN, VIPS, TME, ZUO and SNAP, which are trading for less than $20 a share with the potential to grow in the rest of 2023.
zacks.com
Read More
5 ‘Strong Buy' Stocks Under $10 Are Household Names and Could Explode Higher
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
247wallst.com
Read More
Tencent Music Entertainment: Staying On The Sidelines
Tencent Music Entertainment Group shares surged by +8.3% on May 17 after announcing good Q1 results and guidance, but the stock lost all its gains in the subsequent four trading days. Tencent Music Entertainment's lack of room for profitability improvement and its unattractive valuations have hurt its stock price performance. My rating for Tencent Music Entertainment stock stays as a hold; I am staying on the sidelines till its valuations become more attractive or new catalysts are identified.
seekingalpha.com
Read More
Earnings Estimates Moving Higher for Tencent Music Entertainment Group Sponsored ADR (TME): Time to Buy?
Tencent Music Entertainment Group Sponsored ADR (TME) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zacks.com
Read More
TME vs. RELX: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Internet - Content sector might want to consider either Tencent Music Entertainment Group Sponsored ADR (TME) or RELX PLC (RELX). But which of these two stocks presents investors with the better value opportunity right now?
zacks.com
Read More
Is the Options Market Predicting a Spike in Tencent Music (TME) Stock?
Investors need to pay close attention to Tencent Music (TME) stock based on the movements in the options market lately.
zacks.com
Read More
Does Tencent Music Entertainment Group Sponsored ADR (TME) Have the Potential to Rally 34.59% as Wall Street Analysts Expect?
The mean of analysts' price targets for Tencent Music Entertainment Group Sponsored ADR (TME) points to a 34.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
zacks.com
Read More
7 Stocks Under $50 to Buy (and Never Sell)
While it's a general rule of thumb that you get what you pay for, in the market, you can sneak in some overlooked compelling discounts, which might be the case with the below best affordable stocks to invest in. With a price tag under $50, these enterprises facilitate approachability while also delivering on the quality or relevance components.
investorplace.com
Read More
What Makes Tencent Music Entertainment Group Sponsored ADR (TME) a New Buy Stock
Tencent Music Entertainment Group Sponsored ADR (TME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zacks.com
Read More
South Korea's HYBE signs deal with China's Tencent Music -newspaper
South Korean entertainment company HYBE, home to K-pop superstars BTS, has signed a music distribution deal with China's Tencent, the Seoul Economic Daily newspaper reported on Tuesday citing a HYBE official.
reuters.com
Read More
Tencent Music Entertainment Group (TME) Q1 2023 Earnings Call Transcript
Tencent Music Entertainment Group (NYSE:TME ) Q1 2023 Results Earnings Conference Call May 16, 2023 7:00 AM ET Company Participants Tony Yip - Chief Scientific Officer Cussion Pang - Executive Chairman Ross Liang - Chief Executive Officer Shirley Hu - Chief Financial Officer Conference Call Participants Alex Poon - Morgan Stanley Alicia Yap - Citigroup Lei Zhang - Bank of America Securities Wei Xiong - UBS Xueqing Zhang - CICC Wei Fang - Mizuho Securities Tony Yip Good evening and good morning. Welcome to Tencent Music Entertainment Group's first Quarter 2023 Earnings Webinar.
seekingalpha.com
Read More
China's Tencent Music revenue beats estimates on strong user growth
China's Tencent Music Entertainment Group , on Tuesday reported higher revenue after five straight quarterly declines, driven by growth in paying users on its Spotify-like music streaming platform, sending its U.S.-listed shares up nearly 3% in premarket trading.
reuters.com
Read More
Earnings Previews: Home Depot, iQIYI, Sea Limited, Tencent Music
In mid-morning trading on Friday, the Dow Jones industrials were down 0.17%, the S&P 500 down 0.21% and the Nasdaq 0.33% lower.
247wallst.com
Read More
Artificial Intelligence Engine Predicts TME Stock to Gain 3% by June 2
The world's foremost artificial intelligence stock trading algorithm, An-E, predicts that Tencent Music Entertainment (NYSE: TME ) stock will gain 2.8% by June 2. An-E (pronounced Annie) has made this kind of prediction before.
investorplace.com
Read More
TME or ABNB: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Internet - Content sector might want to consider either Tencent Music Entertainment Group Sponsored ADR (TME) or Airbnb, Inc. (ABNB). But which of these two stocks presents investors with the better value opportunity right now?
zacks.com
Read More
5 Renowned ‘Strong Buy' Stocks Trading Under $10 Have Huge Potential
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
247wallst.com
Read More